260 related articles for article (PubMed ID: 26264631)
1. How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India.
Lahariya C; Paruthi R; Bhattacharya M
Indian J Pediatr; 2016 Apr; 83(4):294-9. PubMed ID: 26264631
[TBL] [Abstract][Full Text] [Related]
2. Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India.
Gupta SK; Sosler S; Lahariya C
Indian Pediatr; 2012 Sep; 49(9):707-9. PubMed ID: 23024078
[No Abstract] [Full Text] [Related]
3. Pentavalent DTP vaccine: need to be incorporated in the vaccination program of India.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2013 Jul; 9(7):1497-9. PubMed ID: 23571225
[TBL] [Abstract][Full Text] [Related]
4. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Black AP; Muller CP
PLoS One; 2020; 15(12):e0242502. PubMed ID: 33290386
[TBL] [Abstract][Full Text] [Related]
5. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.
Gandhi DJ; Dhaded SM; Ravi MD; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Jayanth MV; Ravinuthala S; Sil A; Dhingra MS
Hum Vaccin Immunother; 2016 Apr; 12(4):946-54. PubMed ID: 26580093
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
Klein NP; Abu-Elyazeed R; Cheuvart B; Janssens W; Mesaros N
Hum Vaccin Immunother; 2019; 15(4):809-821. PubMed ID: 30444673
[TBL] [Abstract][Full Text] [Related]
7. Pentavalent vaccine: a major breakthrough in India's Universal Immunization Program.
Bairwa M; Pilania M; Rajput M; Khanna P; Kumar N; Nagar M; Chawla S
Hum Vaccin Immunother; 2012 Sep; 8(9):1314-6. PubMed ID: 22894968
[TBL] [Abstract][Full Text] [Related]
8. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
Faingezicht I; Avila-Aguerro ML; Cervantes Y; Fourneau M; Clemens SA
Rev Panam Salud Publica; 2002 Oct; 12(4):247-57. PubMed ID: 12431356
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
10. An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs.
Lahariya C; Subramanya BP; Sosler S
Indian J Public Health; 2013; 57(1):8-14. PubMed ID: 23649136
[TBL] [Abstract][Full Text] [Related]
11. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.
Ndiritu M; Cowgill KD; Ismail A; Chiphatsi S; Kamau T; Fegan G; Feikin DR; Newton CR; Scott JA
BMC Public Health; 2006 May; 6():132. PubMed ID: 16707013
[TBL] [Abstract][Full Text] [Related]
12. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
Tregnaghi M; López P; Rocha C; Rivera L; David MP; Rüttimann R; Schuerman L
Rev Panam Salud Publica; 2006 Mar; 19(3):179-88. PubMed ID: 16640847
[TBL] [Abstract][Full Text] [Related]
13. Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
Sadoh AE; Nwaneri DU; Ogboghodo BC; Sadoh WE
Vaccine; 2016 May; 34(24):2722-8. PubMed ID: 27108191
[TBL] [Abstract][Full Text] [Related]
14. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
[TBL] [Abstract][Full Text] [Related]
15. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
[TBL] [Abstract][Full Text] [Related]
16. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Bar-On ES; Goldberg E; Hellmann S; Leibovici L
Cochrane Database Syst Rev; 2012 Apr; (4):CD005530. PubMed ID: 22513932
[TBL] [Abstract][Full Text] [Related]
17. Pentavalent vaccine and adverse events following immunization-untangling the misinterpretations.
Malik A
Indian J Pediatr; 2014 Dec; 81(12):1353-7. PubMed ID: 24500059
[TBL] [Abstract][Full Text] [Related]
18. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
Posuwan N; Wanlapakorn N; Vongpunsawad S; Sintusek P; Leuridan E; Van Damme P; Poovorawan Y
Vaccine; 2020 Feb; 38(7):1643-1651. PubMed ID: 31948817
[TBL] [Abstract][Full Text] [Related]
20. Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data.
Sharma A; Kaplan WA; Chokshi M; Hasan Farooqui H; Zodpey SP
BMJ Open; 2015 Feb; 5(2):e007038. PubMed ID: 25712822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
